CVRx (CVRX) Total Current Liabilities (2020 - 2026)
CVRx's (CVRX) quarterly Total Current Liabilities came in at $9.5 million in Q1 2026, up 11.5% year-on-year from $8.5 million in Q1 2025, and down 28.77% quarter-over-quarter from $13.3 million in Q4 2025.
CVRx (CVRX) Total Current Liabilities (2020 - 2026) Analysis & Trends
CVRx's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 11.5% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 11.5% increase from a year earlier, with the FY2025 full-year figure at $13.3 million, up 23.74% from the prior year.
- Total Current Liabilities declined to $9.5 million in Q1 2026 per CVRX's latest filing, from $13.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $13.3 million in Q4 2025 and bottomed at $5.9 million in Q2 2022.
- The 5-year median for Total Current Liabilities is $8.5 million (2025), against an average of $8.9 million.
- Across the five-year window, Total Current Liabilities plunged 76.41% in 2022 and surged 51.04% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $8.1 million in 2022, then declined by 2.77% to $7.9 million in 2023, then surged by 36.85% to $10.8 million in 2024, then increased by 23.74% to $13.3 million in 2025, then dropped by 28.77% to $9.5 million in 2026.
- Per Business Quant, the three latest CVRX Total Current Liabilities figures stand at $9.5 million (Q1 2026), $13.3 million (Q4 2025), and $11.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 8.70 Bn |
| 10 | CVRx | 129.93 Mn | 57.63 Mn | 12.88 Mn | 9.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.49 Mn |
| Dec 31, 2025 | 13.32 Mn |
| Sep 30, 2025 | 11.22 Mn |
| Jun 30, 2025 | 9.69 Mn |
| Mar 31, 2025 | 8.51 Mn |
| Dec 31, 2024 | 10.76 Mn |
| Sep 30, 2024 | 10.95 Mn |
| Jun 30, 2024 | 9.13 Mn |
| Mar 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 7.86 Mn |
| Sep 30, 2023 | 7.41 Mn |
| Jun 30, 2023 | 8.93 Mn |
| Mar 31, 2023 | 7.96 Mn |
| Dec 31, 2022 | 8.09 Mn |
| Sep 30, 2022 | 7.40 Mn |
| Jun 30, 2022 | 5.91 Mn |
| Mar 31, 2022 | 6.59 Mn |
| Dec 31, 2021 | 5.91 Mn |
| Sep 30, 2021 | 8.85 Mn |
| Jun 30, 2021 | 25.04 Mn |